Arteriovenous Malformation

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Genomics
GenomicsUK - Oxford
1 program
Genetics of Arteriovenous MalformationsN/A1 trial
Active Trials
NCT02445430Unknown59Est. Jun 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GenomicsGenetics of Arteriovenous Malformations

Clinical Trials (1)

Total enrollment: 59 patients across 1 trials

NCT02445430GenomicsGenetics of Arteriovenous Malformations

Genetics of Arteriovenous Malformations

Start: May 2015Est. completion: Jun 202359 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space